MedTrace Logo

An mHealth Trial to Promote the Use of Postpartum Contraception

NCT03612518 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 970

Last updated 2018-08-02

No results posted yet for this study

Summary

Multiple encounters of pregnant women with the health care system during the late antenatal and immediate postpartum period provide a gateway for postpartum family planning counselling. Counselling on family planning services during this time is considered effective and cost-efficient for promoting healthy timing and spacing of pregnancies. This research aims to test the effectiveness of mobile phone-based interventions in promoting use of postpartum contraception.

Conditions

  • Contraception Behavior

Interventions

BEHAVIORAL

Text and Voice Messages

Participants in this study arm will periodically receive information regarding antenatal- and postnatal care and family planning services through text and voice messages from the fifth gestational month until the post-partum period of 42 days.

BEHAVIORAL

Interactive Phone Call

Participants in this study arm will receive information regarding antenatal- and postnatal care and family planning services through periodic interactive phone calls from the fifth gestational month until the post-partum period.

Sponsors & Collaborators

  • Junaid-ur-Rehman Siddiqui

    lead OTHER

Principal Investigators

  • Xaher Gul, DrPH(c) · Marie Stopes Society

  • Waqas Hameed, MSc · Marie Stopes Society

  • Junaid-ur-Rehman Siddiqui, BBA · Marie Stopes Society

  • Sharmeen Hussain, MPH · Marie Stopes Society

  • Ishaque Sheikh, MSc · Marie Stopes Society

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
44 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-15
Primary Completion
2019-08-01
Completion
2019-08-01

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03612518 on ClinicalTrials.gov